Showing results (11-20 of 222) with videos related to
Sort By:
Pageof 23
Circulation|September 1, 2005
Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstrictionZhigang Hong, Andrew J Smith, Stephen L Archer, et al.Advances in Experimental Medicine and Biology|June 26, 2016
Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic ImplicationsStephen L ArcherEuropean Heart Journal|January 9, 2007
The making of a physician-scientist--the process has a pattern: lessons from the lives of Nobel laureates in medicine and physiologyStephen L ArcherHealthcare Management Forum|July 9, 2020
Providing care for the 99.9% during the COVID-19 pandemic: How ethics, equity, epidemiology, and cost per QALY inform healthcare policyStephen L ArcherCJC Open|May 24, 2021
Hemodynamic Characteristics and Outcomes of Pulmonary Hypertension in Patients Undergoing Tricuspid Valve Repair or ReplacementMahima Vijayaraghavan, Kurt W Prins, Sasha Z Prisco, et al.The Journal of Laboratory and Clinical Medicine|September 14, 2002
Redox signal transduction: reductive reasoningDouglas Peterson, E Kenneth WeirCardiovascular Research|July 11, 2006
Role of ion channels in acute and chronic responses of the pulmonary vasculature to hypoxiaE Kenneth Weir, Andrea OlschewskiPharmacology & Therapeutics|June 23, 2007
Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertensionSébastien Bonnet, Stephen L ArcherAdvances in Experimental Medicine and Biology|March 6, 2010
A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertensionJalees Rehman, Stephen L ArcherPageof 23